Abstract Antibody-dependent cellular cytotoxicity (ADCC) is dependent on the fucose content of oligosaccharides bound to monoclonal antibodies (MAbs). As MAbs with a low fucose content exhibit high ADCC activity, it is important to control the defucosylation levels (deFuc%) of MAbs and to analyze the factors that affect deFuc%. In this study, we observed that the deFuc% was inversely related to culture medium osmolality for MAbs produced in the rat hybridoma cell line YB2/0, with r 2 values as high as 0.92. Moreover, deFuc% exhibited the same correlation irrespective of the type of compound used for regulating osmolality (NaCl, KCl, fucose, fructose, creatine, or mannitol) at a culture scale ranging from 1 to 400 L. We succeeded in controlling MAb deFuc% by maintaining a constant medium osmolality in both perfusion and fed-batch cultures. In agreement with these observations, reverse transcription PCR analyses revealed decreased transcription of genes involved in glycolysis, GDP-fucose supply, and fucose transfer under hypoosmotic conditions.
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Introduction
The contribution of biopharmaceutical industries to general healthcare is rapidly increasing, with over 165 such industries having been approved globally since 1982 (Walsh 2006) . Within the therapeutic applications of biopharmaceuticals, monoclonal antibodies (MAbs) are of growing interest (Burnouf 2011; Grillberger et al. 2009; Mori et al. 2007) , and are generally administered as active proteins in large amounts and at high protein concentrations, unlike other aqueous proteinaceous biopharmaceuticals such as cytokines.
As protein molecules tend to aggregate at high concentrations, extreme care must be taken during the manufacture of MAb solutions to prevent this from happening, as it could lead to fouling of aseptic filters during manufacture or immunogenic reactions in patients (Ishikawa et al. 2010b) . Although MAbs have low side effects compared with other pharmaceuticals because of their high antigen specificities, minimization of their immunogenicity is nevertheless still important (Ishikawa et al. 2010a ). Thus, enhancement of MAb activities is desirable in order to reduce the dose requirement. This will not only widely shift manufacturing and supply systems by reducing the amount and solution concentration of MAb, but will also lower MAb immunogenicity.
Antibody efficacies critically depend on the structure of the oligosaccharides attached to the polypeptide as well as the amino acid sequences of the heavy and light chains. IgG1 has two N-linked oligosaccharide chains bound to the Fc region. The oligosaccharides are of the complex biantennary type, composed of a trimannosyl core structure with or without core fucose, bisecting N-acetylglucosamine (GlcNAc), galactose, and terminal sialic acid, all of which give rise to structural heterogeneities. These heterogeneities make comparability control difficult because of differences in pharmacokinetics, pharmacodynamics, and immunogenicity (Putnam et al. 2010) . Antibody-dependent cellular cytotoxicity (ADCC) is triggered upon binding of the antibody Fc region to lymphocyte receptors (FccRs), and is dependent on the content of the fucose attached to the innermost GlcNAc of the N-linked Fc oligosaccharide, so is dramatically enhanced by a reduction in the fucose content Shields et al. 2002; Shinkawa et al. 2003) .
Non-fucosylated therapeutic antibodies show 50-1,000-fold higher efficacy than their fucosylated counterparts. It has been demonstrated that the MAbs produced in a rat myeloma cell line (YB2/0) exhibit higher ADCC activity than MAbs produced in Chinese hamster ovary (CHO) or NS0 myeloma cells (Kanda et al. 2006) . This is because YB2/0 cells produce MAbs with a lower fucose content than those by CHO or NS0 cells. Although YB2/0 appears to be a good candidate for the large-scale production of high activity MAbs, there have been limited reports about the bio-process development in these cells to be employed with confidence (Arathoon and Birch 1986; Keen 1995; Konno et al. 2011; Rhodes and Birch 1988; Teylaert et al. 2011 ). In addition, we have observed that the defucosylation levels (deFuc%) of oligosaccharides in MAbs produced by YB2/0 vary according to cell culture conditions (unpublished observations).
In this article, we show that osmolality is one of the critical process parameters responsible for controlling the deFuc% and, eventually, the ADCC activity. We also discuss the molecular bases of this phenomenon.
Materials and methods

Cell culture
Rat hybridoma YB2/0 cells (ATCC CRL-1662, Manassas, VA) were used as the host cell line (Shitara et al. 1994) . A YB2/0 cell line expressing proprietary recombinant mouse/human chimeric IgG1 antibodies A and B was cultured in suspension in Hybridoma SFM or CD-Hybridoma medium (Life Technologies, Carlsbad, CA) with appropriate supplements in a 250-mL Erlenmeyer flask (Corning, Corning, NY) or various sized bioreactors: 1 L with flat paddle (ABLE, Tokyo, Japan); 30 L with Ruston (Bioengineering AG, Wald, Switzerland); and 5 and 400 L with pitched paddle blade (Marubishi Bioeng., Tokyo, Japan). The medium was provided in powder form and osmolality was adjusted via the amount of powder used.
Cells were inoculated at a density of at least 2 9 10 5 cells/mL and cultured at 37°C with occasional feeding with amino acids and vitamins from serum-free Iscove's Modified Dulbecco's Medium until the decline phase. In 1-L bioreactor cultures, the culture was maintained at pH 7.1 by a CO 2 gas overlay and 1 mM Na 2 CO 3 alkaline solution at 50% dissolved oxygen by sparger O 2 gas. The perfusion system equipped with the Sorvall Centritech TM Lab II system (Thermo, Waltham, MA) arbitrarily controlled the medium osmolality at 4-day intervals in a stepwise fashion. The perfusion rate was set at 1 volume of fresh medium per working volume of reactor per day (vvd). For comparison, the anchoragedependent SP2/0 (ATCC, CRL-1581) and NS0 cell lines (Riken, RCB0213, Ibaraki, Japan) expressing recombinant mouse/human chimeric IgG1 antibody A were cultured in cell culture bags (Medtronic, Minneapolis, MN) and 225 cm 2 T-flasks (AGC, Tokyo, Japan).
Cell culture monitoring
The number of viable and dead cells was determined using a CEDEX TM counter (Innovatis AG, Bielefeld, Germany) by the trypan blue dye exclusion method. Off-line measurements of culture glucose and lactate were carried out using a YSI 2700 bioanalyzer (Yellow Springs Inc., Yellow Springs, OH). The concentration of MAbs in the culture supernatant was determined by high performance liquid chromatography (HPLC) using a Protein A column. Medium osmolality was measured by a Vogel osmometer OSMOMAT 030-D (Vogel, Giessen, Germany) using freezing-point depression. Fucosylation levels were measured as the monosaccharide composition of each purified MAb, as previously described (Shinkawa et al. 2003) . Total cellular RNA was isolated as described previously (Shinkawa et al. 2003) and reverse transcription polymerase chain reaction (RT-PCR) analyses were carried out as previously reported for the a-1,6-fucosyltransferase gene (FUT8) and GDP-mannose 4,6-dehydratase gene (GMD) (Kanda et al. 2006 ) and GDP-fucose metabolic pathway gene expression (Yoshisue et al. 2002) . Table 1 lists the specific primers used.
Results and discussion
Effects of initial culture medium osmolality on deFuc%
Osmolality is an important parameter in the mammalian cell culture process. The reported effects of osmolality on production yield, glycosylation, site occupancy, and sialylation are summarized in Table 2 . At the beginning of YB2/0 cell culture, the MAb deFuc% was increased with the dilution (which lowers the osmolality) of basal medium (Fig. 1) . For the fed-batch culture in a 5-L bioreactor, various osmolalities of the initial basal media were obtained by dilution with distilled water (285, 300, 325, and 345 mOsm/kg). The deFuc% of MAbs was found to be inversely related to the osmolality (70% at 285 mOsm/kg vs. 40% at 345 mOsm/kg). Although protein production and specific MAb production rate (SPR) are known to be affected by culture medium osmolality Park and Lee 1995; Zhang et al. 2010) , no significant changes were observed in the amount of MAb produced under the conditions employed in the present study. To our knowledge, osmolality has not been previously been used for controlling glycosylation patterns. In fact, Kimura and Miller reported that cell culture osmolality did not significantly affect the monosaccharide content of the tissue plasminogen activator expressed in CHO cells (Kimura and Miller 1997) . It is unclear whether the difference in the observed effects of osmolality can be ascribed to differences in cells used or proteins analyzed.
Effect of dilution at the mid-phase of fed-batch culture on deFuc%
The inverse relationship between deFuc% and medium osmolality was also observed following dilution (with distilled water) at the mid-phase of YB2/0 cell culture. Osmolality is influenced by various growth environments, including the addition Cytotechnology (2012) 64:249-265 251 of alkaline solutions (for pH adjustment) and feed solutions (containing glucose and amino acids), as well as by the accumulation of by-products. For fedbatch culture in a 5-L bioreactor, the osmolality of the initial basal medium was set at 290 and 340 mOsm/kg by dilution with distilled water. To mimic changes in osmolality, the 340 mOsm/kg culture was diluted on day 6 with distilled water to reduce its osmolality to 290 mOsm/kg. As a result, deFuc% in MAb glycosylation was increased by 20% and became comparable with that observed in the sample cultured at 290 mOsm/kg throughout. This indicates that the deFuc% depends on the osmolality of the culture medium when the MAbs are produced, but not on the osmolality of the initial culture medium. These data also suggest that the deFuc% can be controlled by varying medium osmolality even during culture periods, irrespective of initial culture conditions. deFuc% control has previously been obtained by cell line engineering, including FUT8 knock-out ) and GMD knock-out ) of host cell lines, expression of small interfering RNA (siRNA) against FUT8 (Mori et al. 2004) or GDP-fucose transporter gene (GFT) (Omasa et al. 2008) , and use of the glycosidase inhibitor Kifunensine (van Berkel et al. 2010; Zhou et al. 2008) . The practical control of MAb deFuc% in process development areas, however, has not been reported thus far.
Effects of different cell lines on deFuc%
The inverse relationship between deFuc% and culture osmolality was also observed in other cells that are used to produce MAbs, in addition to YB2/0 cells. The number of cell lines that can be employed for the production of MAbs for the market is limited, and includes CHO or mouse myeloma cell lines (NS0 or SP2/0). Since deFuc% in MAb glycosylation must be regulated for ADCC quality control, it is important to understand the effects of culture conditions on deFuc% in each cell line. Thus, we evaluated the effects of osmolality in NS0 and SP2/0 cell lines (Fig. 2) . Although the detailed osmolality dependence of deFuc% was somewhat different among the three cell lines studied, we observed a general inverse relationship between deFuc% and osmolality of the and CS13*-1.00) The cell line with a lower cloned gene dosage displayed more significant enhancement in qAb and less reduction in l at hyperosmolality. However, the cell line with a higher cloned gene dosage still yielded a higher maximum Ab concentration at hyperosmolality up to 469 mOsm/kg (Ryu et al. 2001) 300-500 tPA rCHO [l-15500 (ATCC CRL-9606)] The osmotic pressure was shifted up or down during growth and production phases. The l was higher at a lower osmotic pressure after the shift. The specific tPA production rate was increased by the shift irrespective of the direction (up or down), and cyclical changes in osmolality improved the production 1.13-fold compared with that attained under constant osmotic pressure (Takagi et al. 2001) Cytotechnology (2012) 64:249-265 253 osmolalities between 410-450 mOsm/kg, yields the best production conditions; NaCl hampered viral infectious production, while fructose leads to lower cell yields (Coroadinha et al. 2006) Osmoprotective compounds to N-glycolylneuraminic acid (Neu5Gc) forms of sialic acid levels, as they remained unchanged between the conditions (Borys et al. 2010) Optimized cell growth 40-250 mM NaCl -Hela Optimal NaCl concentration was 100-300 mM for growth and DNA synthesis (Stubblefield and Mueller 1960) culture medium in NS0 and SP2/0 cells as well as in YB2/0 cells. ADCC activity is greatly dependent on the deFuc% of MAb oligosaccharides, so appropriate selection of host cells is particularly relevant when the ADCC is the intended activity of MAb. This is because different host cell lines exhibit distinct glycosylation patterns (especially fucosylation), and MAbs produced in a particular host will demonstrate a specific ADCC activity (Shields et al. 2002; Shinkawa et al. 2003; Wurm 2004 ). In the purpose of adopting a quality by design (QbD) policy (FDA 2009), a reasonable choice would be to use the engineered host cell line for robust control, such as the development of a CHO host cell line with FUT8 knock-out . Such a strategy is, however, not always possible in actual development. Biopharmaceutical developments take about 12 years from discovery through registration, and are often carried out in different organizations and in multiple firms depending on the development stage (Steinmeyer and McCormick 2008; Werner 2004) . Thus, it is not always practical to change the host cells at a later stage. Not only will clinical data have been accumulated regarding the engineered hosts, but such a change involves altering cell banks and controlling comparability. A method to control deFuc% by culture conditions, irrespective of cell line, would be of great benefit for biopharmaceutical production in which many cell lines are used as hosts: mouse myeloma line NS0, SP2/0, hamster CHO, BHK, dog MDCK, human HEK293, MRC-5, and HT-1080.
Controlling deFuc% in perfusion culture
The deFuc% was controlled arbitrarily from 45 to 85% by feeding media with different osmolalities (260-330 mOsm/kg) into perfusion cultures (Fig. 3a) . The deFuc% was found to be increased/decreased to intended levels (solid squares) when the reactor osmolality (open circles) reached the targeted value by introducing media of lower/higher osmolalities (filled diamonds). Although deFuc% could be controlled by regulating medium osmolality, cell viability was decreased at the very low osmolality of 240 mOsm/kg (Fig. 3b, c, arrows) . Thus, it is important to keep in mind that the regulation of medium osmolality by dilution with distilled water has limitations regarding cell viability and unduly low concentrations of critical components.
Effects of compounds used to adjust medium osmolality on deFuc%
The deFuc% was inversely correlated with osmolality, irrespective of the compounds used to adjust osmolality (ionic vs. non-ionic or substrate vs. non- Initial medium osmolality (mOsm/kg) Defucosylated MAbs (%) substrate) (Fig. 4) . To determine whether the colligative value of osmolality simply affects the deFuc%, or whether the chemical/biochemical properties of the compound used to adjust osmolality influence the deFuc%, we added either an ionic compound (NaCl or KCl), a substrate (fucose, fructose, or creatine), or a non-substrate (mannitol) to the medium diluted with distilled water to 250 mOsm/kg (from 320 mOsm/kg). Cells were then cultured at 37°C for 11 days in the 250 mL Erlenmeyer flasks. Surprisingly, the effects of different compounds obeyed the same correlation (with the r 2 value being as high as 0.92, Fig. 4) , and KCl exhibited the same effect as NaCl, even though the Na ? /K ? balance is generally regarded as critical in cell culture. Although it was unexpected that fucose supplementation did not increase fucosylation levels (i.e., decrease the deFuc%), it is known that GDP-fucose, the substrate for fucosylation, is derived mainly (90%) from GDPmannose (Becker and Lowe 2003) . The conversion of free fucose (transported into the cytosol from extracellular medium or from lysosomes after catabolism of fucosylated glycans) to GDP-fucose is a minor salvage pathway, which explains why the addition of fucose resulted only in an increase in osmolality. SPR is also known to depend on medium osmolality. The extent of this effect, however, varies between osmolytes (Coroadinha et al. 2006) , in contrast to the effect on deFuc%.
Although the QbD approach would be conceptually beneficial, its application to the actual control of cell culture processes is not always straightforward. Fig. 3 Defucosylation levels (deFuc%) of MAbs produced by YB2/0 cells cultured under various osmolalities. Cells were cultured by a perfusion method that enabled arbitrary changes to be made to the medium osmolality. a Open circles observed medium osmolality, closed diamonds osmolality of feeding medium, closed squares observed deFuc%. b Reactor cell viability (open triangles). c Reactor viable cell density (closed circles). Reproducibility is ensured because several conditions were adopted, although reproducibility is just one aspect of perfusion culture One reason for this is that process parameters involved in culture are complex and inter-dependent, even though they are usually optimized by design of experiment (DOE)-based strategies Horvath et al. 2010) . Under these circumstances it would be advantageous to determine the critical parameter that directly affects the quality of the product, such as medium osmolality (on deFuc%) as demonstrated in this study.
Effect of different physical conditions on deFuc%
In industrial manufacturing, scale-up processes involve changes to various physical conditions such as aspect ratio, size of reactors, impeller type, and sparger pore-size. Moreover, the increased liquid volume per surface area involved in scale-up leads to accumulation of dissolved carbon dioxide (dCO 2 ) (Matsunaga et al. 2009 ). This lowers the expression of MAbs in several cell types (deZengotita et al. 1998; Goudar et al. 2007; Zhu et al. 2005) due to altered biochemical conditions within the cells, which in turn alters the deFuc%. We analyzed the relationship between the deFuc% and medium osmolality for four types of culture scales (1, 5, 30, and 400 L). Cells were cultured at 37°C for 11 or 12 days with various initial medium osmolalities in reactors of different sizes as well as with different blades and aspect ratios. The deFuc% was still found to be inversely correlated with osmolality irrespective of reactor size, with r 2 values as high as 0.79 (Fig. 5) . Thus, the deFuc% was not affected by different physical conditions other than osmolality in fed-batch cultures.
Previous reports on the bio-process development of mammalian cell culture discussed site-occupancy, antennary structure, and sialylation of oligosaccharides attached to proteins, and the major physical factors shown to affect these properties included ammonia, pH, dissolved oxygen, temperature, harvest-criteria (Butler 2006; Goochee et al. 1991; Hossler et al. 2009 ), and dCO 2 (Kimura and Miller 1997; Oliveira et al. 2008; Zanghi et al. 1999 ). However, no reports have yet analyzed the effect of these physical conditions on deFuc%.
RT-PCR analysis of cultured YB2/0 cells in bioreactors
Semi-quantitative RT-PCR analysis was performed to elucidate changes in mRNA expression levels of FUT8 and GMD in YB2/0 cells during an 11-day fedbatch culture in 400-L reactors (Fig. 6 ). After day 6, the ratio of FUT8 versus b-actin (control) increased markedly, following the increase in medium osmolality from 300 to 450 mOsm/kg, up to approximately 8-fold (relative to day 0 of pre-culture) at the late-phase of culture; in response to this increase in the medium osmolality, the deFuc% decreased from 55 to 35%. On the other hand, the ratio of GMD versus b-actin exhibited only a small increase. These observations suggest that activities of enzymes involved in MAb fucosylation are correlated with medium osmolality. We therefore next analyzed the effects of medium osmolality (hypo-vs. hyperosmolality) on the gene expression of enzymes involved in fucose metabolism and glycolysis.
Effects of medium osmolality on gene expression of GDP-fucose metabolism
Under hypoosmotic conditions, gene expression of enzymes involved in the utilization and synthesis of GDP-fucose and in glycolysis was found to be reduced in comparison with hyperosmotic conditions. We compared gene expression under hypoosmotic versus hyperosmotic conditions by microarray followed by RT-PCR analyses. cDNAs were prepared from mRNAs extracted from YB2/0 cells expressing IgG1 B that were sampled on days 6, 9, 11, and 12 during serum-free 1-L fed-batch culture in hypoosmotic (250 mOsm/kg) and hyperosmotic (410 mOsm/kg) media. Microarray analyses indicated that hypoosmotic conditions led to the downregulation of glycolysis gene expression, particularly pyruvate kinase and aldolase (data not shown), which is in agreement with the proteomic and transcriptomic analyses of the effects of osmotic stress on CHO and hybridoma (Shen and Sharfstein 2006; Shen et al. 2010) . Next, we used semi-quantitative RT-PCR to evaluate gene expression under hypoosmotic versus hyperosmotic conditions and observed three marked responses (Table 3) . First, under hypoosmotic conditions, the key enzymes of glycolysis, glucokinase, and hexokinase 1 were strongly down-regulated. The values did not vary significantly with the culture period because the relative (hypoosmotic vs. hyperosmotic) osmolality did not vary with time, in contrast to the case of Fig. 6 . Although the glucose consumption and lactate production were lower in hypoosmotic compared with hyperosmotic cultures, there were no significant differences in growth or viabilities (data not shown). These observations suggest that specific glucose consumption and lactate production are decreased under hypoosmotic conditions. Second, expression of the gene group of the GDP-fucose supply pathway is decreased under hypoosmotic conditions. The synthesis of GDPfucose in mammalian cells involves both the GDPmannose-dependent de novo pathway and the free fucose-dependent salvage pathway. Quantitative studies of fucose metabolism in HeLa cells indicate that more than 90% of GDP-fucose is derived from the de novo pathway, even in cells fed with fucose (Becker and Lowe 2003) . Expression of GMD in the de novo pathway (Table 3 ; Fig. 6 ) and L-fucose kinase in the salvage pathway (Table 3) was decreased under hypoosmotic conditions, suggesting that the supply of GDP-fucose is limited under hypoosmotic conditions. Third, the expression of FUT8, which is responsible for the fucosylation of MAb oligosaccharides and requires the substrate GDP-fucose, was markedly decreased under hypoosmotic conditions. These results suggest that the control of medium osmolality is critical for the production of MAbs with a constant deFuc%, and hence ADCC activity in these cell lines. The effects of osmolality on recombinant protein expression and glycosylation have been previously reported (Borys et al. 2010) ; however, no description was made regarding fucosylation.
Controlling glycosylation patterns in fed-batch culture
Based on the findings obtained in this study, a new simple method was devised for the industrial-scale production of MAbs with high deFuc%. Although fed-batch is the most common industrial method for MAb production, it is difficult to control the reactor osmolality throughout the culture period because it is affected by many factors, including the addition of alkaline solutions for pH adjustment, accumulation of dCO 2 (which affects the buffer property), consumption of nutrients, and accumulation of product and various byproducts. In addition, since the tank size limits the volume of feed solutions, dilution is not practical for industry-level production. Thus, a method of reducing osmolality without dilution would be extremely useful. We employed custom-made medium containing a low concentration of sodium chloride. We varied and controlled the glucose concentration in order to regulate the osmolality, because glucose is a nutrient contained at a high initial concentration and is consumed and metabolized by cells. In the presence of a high glucose concentration, the osmolality decreased steadily throughout the culture period due to glucose consumption. It was appended on days 8 and 9 to sustain cell viability while achieving hypoosmotic conditions (Fig. 7a, b , cross symbols). An increase in osmolality (hyperosmotic conditions) could be achieved by supplementing with glucose from day 6 and on days 8 and 9 (Fig. 7a, b , open symbols). Constant medium osmolality could be attained by the addition of glucose on days 2-9 in addition to other nutrients (closed symbols). The observed deFuc% values of the MAbs harvested on day 11 were inversely correlated with osmolality, as expected (Fig. 7b, c) . Moreover, the viable cell density observed under hypoosmotic conditions, under which the highest deFuc% was attained, was Defucosylation levels (deFuc%) of MAbs produced with different methods to regulate medium osmolality. Open symbols hyperosmotic, cross symbols hypoosmotic, closed symbols constant osmotic conditions. Cells were cultured in a 5-L fed-batch bioreactor with custom-made medium containing low NaCl. Osmolality was adjusted by supplementing with NaCl. a glucose concentration in the medium, b medium osmolality, c deFuc% MAbs harvested on day 11, and d viable cell density. Independent experiments under similar conditions exhibited similar initial results in 1-L bioreactors comparable to that observed under constant osmolality (Fig. 7d) . These results suggest that osmolality can be regulated, such that MAb deFuc% can also be controlled arbitrarily in the fed-batch culture. Approximately 70% of therapeutic proteins and biologic candidates are glycoproteins (Sethuraman and Stadheim 2006) . Variation in glycoforms can be seen in site-occupancy (macroheterogeneity) and in the structure of attached glycans (microheterogeneity) (Butler 2006) . Glycosylation is a critical protein quality attribute that can modulate the efficacy of a commercial therapeutic glycoprotein (Hossler et al. 2009 ). One example for this is fucosylation, which affects bioactivities such as heparin binding of antithrombin (Garone et al. 1996) as well as ADCC of MAbs. Currently, it is impossible to control total enzymatic activities in cells by regulating culture conditions. The regulation of medium osmolality with glucose is, however, sufficient for achieving a desirable deFuc% necessary for efficacious ADCC in YB2/0 cell culture. The present method to control deFuc% by medium osmolality opens the way to using mammalian cells that are unsuitable for glycoprotein production because of unwantedly high and/ or uncontrollable fucose content in the oligosaccharides attached to the protein.
Conclusion
In this study, we found that osmolality is a critical process parameter in the control of deFuc% for recombinant glycoprotein production in fed-batch and perfusion cultures of YB2/0 and other cell-lines. We showed that low medium osmolality directly results from the suppression of mRNA expression levels of various enzymes involved in glycolysis, GDP-fucose supply, and fucose transfer. Elucidation of these critical conditions is beneficial and complementary to the DOE strategy that comprehensively evaluates the effects of various parameters on the attributes.
